This week in transparency news: January 26 – February 1, 2019

by Staff writer,
Posted on 2/1/2019

Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:

U.K. Committee Warns Universities over Failures to Report Clinical Trials STAT

Letters were sent to more than 36 universities in the U.K. warning that if clinical trial results reporting does not improve, they would have to appear before Parliament. This follows a report from last year that was referred to as “deeply disappointing.”

Read the story here.

Higher Education Discount Pricing Model Announced for Clinical Trial Disclosure Reporting SoftwareClinical Research News

Research shows that only 11 percent of universities post clinical trial results to the European Clinical Trial Register (EUCTR) within required timeframes, according to a recent BMJ report. TrialAssure is combatting this, and price sensitivity, by creating the TrialAssure Academic Pricing (TAP) model.

Learn more about the program.

European Union: Transparency of Pre-Clinical and Clinical Trial Data in the EU Mondaq

A recent article by lawyer Jacqueline Mulryne reviews proactive and reactive disclosure in the European Union (EU), discussing transparency of documents, commercially confidential information, court cases on disclosure of clinical trials, a summary of data held by the European Medicines Agency (EMA), practical tips, and more.

Read the full article.

Share: